Tryptamine
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 20 Nov 2025
- Reported shorts
- 6
- Shares on issue
- 1.560B
Tryptamine (TYP) Short Interest
Tryptamine (ASX:TYP) had 0.00% of shares reported as short positions as of 20 Nov 2025, representing 6 shares. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Tryptamine
Tryptamine (TYP) is an ASX-listed company focused on the research and development of novel therapeutic compounds. The company aims to address unmet medical needs through innovative drug discovery and clinical trials. Further details regarding their specific market position and unique value proposition are unavailable without additional information.
Company profile →Tryptamine (ASX:TYP) has 0.00% of its shares on issue reported as short positions as of 20 Nov 2025, or about 6 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads TYP today
- Zanger BreakoutWatchScore 18rank 1342 of 1942
- CAN SLIMNot a candidate
- Minervini Trend TemplateWatchScore 26rank 658 of 1716
- Crowded-Short BreakoutWatchScore 9rank 1210 of 1502
- Quality compoundersNot a candidate
Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
Company details
Company information is being updated. Check back soon.
Be the first to discuss TYP
Start a research thread or post the first pulse update